Zhengye Biotechnology Holding (ZYBT) Dividends payables (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Dividends payables of $304000.0 for Q2 2025, up 5.7% quarter-over-quarter from $287619.7 in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Dividends payables (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Dividends payables for 3 consecutive years, with $304000.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Dividends payables changed N/A year-over-year to $304000.0; the TTM figure through Jun 2025 stood at $304000.0 (changed N/A YoY), while the FY2024 annual figure was $287619.7, down 86.77% from the prior year.
- Dividends payables rose to $304000.0 in Q2 2025 per ZYBT's latest filing, from $287619.7 in the prior quarter.
- Across five years, Dividends payables topped out at $2.2 million in Q4 2023 and bottomed at $287619.7 in Q4 2024.
- Historically, Dividends payables has averaged $921828.4 across 3 years, with a median of $304000.0 in 2025.
- On a YoY basis, Dividends payables climbed as much as 86.77% in 2024 and fell as far as 86.77% in 2024.
- Zhengye Biotechnology Holding's Dividends payables stood at $2.2 million in 2023, then plunged by 86.77% to $287619.7 in 2024, then gained by 5.7% to $304000.0 in 2025.
- Business Quant data shows ZYBT's Dividends payables at $304000.0 in Q2 2025, $287619.7 in Q4 2024, and $2.2 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 221.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 304,000.00 |
| Dec 31, 2024 | 287,619.68 |
| Dec 31, 2023 | 2.17 Mn |